Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-25-082527·MILLENNIUM MANAGEMENT LLC
Schedule 13G ownership disclosure
Phathom Pharmaceuticals Inc
Common Stock, par value $0.0001 per share · CUSIP: 71722W107
Event date: 2025-08-19
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Integrated Core Strategies (US) LLC
Shares: 3,588,650.00 · Class: 5.1%
- Millennium Management LLC
Shares: 4,160,515.00 · Class: 5.9%
- Millennium Group Management LLC
Shares: 4,160,515.00 · Class: 5.9%
- Israel A. Englander
Shares: 4,160,515.00 · Class: 5.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-082527
- Form type
- SCHEDULE 13G/A
- Filer
- MILLENNIUM MANAGEMENT LLC
- CIK
- CIK 1273087
- Filed
- Aug 25, 2025
- Reporting period
- Aug 19, 2025
- Description
- Schedule 13G beneficial ownership